argenx parlays myasthenia gravis data into year’s second-largest follow-on at $750M

In the year’s second-largest follow-on to date, argenx raised $750 million through the sale of 2.6 million ADSs at $205 and 1.1 million shares at €186.52 ($205.25).

The price is a 3% discount to the stock’s close of $212.12 on Tuesday, when argenx S.E. (Euronext:ARGX; NASDAQ:ARGX) proposed after hours to raise $500 million. ...